Thousands of men claim finasteride, a drug that many start taking in their 20s and 30s to avoid hair loss, has left them with ...

Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment ...

Hims & Hers Health's stock dropped 25% due to Amazon’s competition. Learn why HIM stock's 38% upside and strong growth make ...

Shares of Hims & Hers (HIMS) are sliding on Thursday ... $10/month for anti-aging skin care, and $19/month for ED. AMAZON ONE MEDICAL PAY-PER-VISIT: Amazon has introduced its Amazon One Medical ...

Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and ...

Hims & Hers Health (HIMS, Financials) shares slumped 24.5% on Thursday as Amazon (AMZN, Financials) expanded into hair loss and erectile dysfunction treatment sectors; shares are recovering ...

Shares of Hims & Hers (NYSE: HIMS) is down big this week after Amazon (NASDAQ: AMZN) announced its expansion into telehealth. The market thinks this is terrible news, but is it? Travis Hoium ...

Investing.com -- Shares of Hims & Hers Health ... anti-aging skincare, ED, and motion sickness, all with upfront pricing. Amazon touts the service as offering convenience and affordability ...

Hims & Hers' GLP-1 Supply Tracker saw nearly 7,000 reports of access issues in its first week, especially for semaglutide-based medications. Nearly 80,000 users reported issues accessing branded ...

Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded GLP-1s on the market. The tracker allows patients to self-identify ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Hims & Hers Health Inc (Symbol: HIMS), where a total of 229,231 contracts have traded ...